1-4 of 4
Patrick H. Maxwell
Close
Sort by
Journal Articles

Dysregulation of the HIF pathway due to VHL mutation causing severe erythrocytosis and pulmonary arterial hypertension

Jonathan Bond, Daniel P. Gale, Thomas Connor, Stuart Adams, Jasper de Boer, Duncan M. Gascoyne, Owen Williams, Patrick H. Maxwell, Philip J. Ancliff
Journal: Blood
Blood (2011) 117 (13): 3699–3701.
https://doi.org/10.1182/blood-2010-12-327569
Published: 2011
Journal Articles

Autosomal dominant erythrocytosis and pulmonary arterial hypertension associated with an activating HIF2 α mutation

Daniel P. Gale, Sarah K. Harten, Cecil D. L. Reid, Edward G. D. Tuddenham, Patrick H. Maxwell
Journal: Blood
Blood (2008) 112 (3): 919–921.
https://doi.org/10.1182/blood-2008-04-153718
Published: 2008
Journal Articles

Lack of endothelial cell survivin causes embryonic defects in angiogenesis, cardiogenesis, and neural tube closure

Femke Zwerts, Florea Lupu, Astrid De Vriese, Saskia Pollefeyt, Lieve Moons, Rachel A. Altura, Yuying Jiang, Patrick H. Maxwell, Peter Hill, Hideyasu Oh, Claus Rieker, Désiré Collen, Simon J. Conway, Edward M. Conway
Journal: Blood
Blood (2007) 109 (11): 4742–4752.
https://doi.org/10.1182/blood-2006-06-028068
Published: 2007
Includes: Supplemental data
Journal Articles

Long-term reversal of chronic anemia using a hypoxia-regulated erythropoietin gene therapy

Katie Binley, Zoe Askham, Sharifah Iqball, Hayley Spearman, Leigh Martin, Mahesh de Alwis, Adrian J. Thrasher, Robin R. Ali, Patrick H. Maxwell, Susan Kingsman, Stuart Naylor
Journal: Blood
Blood (2002) 100 (7): 2406–2413.
https://doi.org/10.1182/blood-2002-02-0605
Published: 2002